Additionally, it addresses the FDA’s communications While using the applicant, the retention of records that assist the SE report, confidentiality of the SE report, how an applicant can amend or withdraw an SE report, how an applicant may perhaps transfer possession of an SE report back to a brand new applicant and Digital submission from the SE